dc.contributor.author
Sánchez Milán, Jose Antonio
dc.contributor.author
Mulet, Maria
dc.contributor.author
Molet, Itziar
dc.contributor.author
Lisa Molina, Julia
dc.contributor.author
Font Alberich, Maria
dc.contributor.author
Lorca, Cristina
dc.contributor.author
Gea Sánchez, Montserrat
dc.contributor.author
Bellon, Filip
dc.contributor.author
Batalla, Iolanda
dc.contributor.author
Meana, Javier
dc.contributor.author
Callado, Luis
dc.contributor.author
Morentin, Benito
dc.contributor.author
Ramos Miguel, Alfredo
dc.contributor.author
Kalaria, Raj
dc.contributor.author
Serra Maqueda, Aida
dc.contributor.author
Gallart Palau, Xavier Ramon
dc.date.accessioned
2026-03-09T19:31:47Z
dc.date.available
2026-03-09T19:31:47Z
dc.identifier
https://doi.org/10.1186/s40478-026-02223-z
dc.identifier
https://hdl.handle.net/10459.1/469747
dc.identifier.uri
https://hdl.handle.net/10459.1/469747
dc.description.abstract
Schizophrenia (SZ) is epidemiologically linked to an increased risk of developing age-related dementias (ARD) predominantly characterized by Alzheimer's disease and vascular dementia. However, the molecular mechanisms underlying this association remain insufficiently elucidated. Extracellular vesicles (EVs) play a critical role in neuropathological processes and offer a promising avenue for identifying shared disease mechanisms and potential circulating markers for patient stratification. Here we used a two-phase systems biology approach integrating discovery-driven proteomics with a targeted validation strategy using data-independent acquisition mass spectrometry (DIA-MS) in a large, independent SZ cohort. First, we analyzed brain-derived EVs (bEVs) from post-mortem SZ and ARD subjects to identify shared molecular signatures. Next, we validated the presence and circulation of these bEV markers in circulating plasma EVs (pEVs) using DIA-MS data. Remarkably, SZ and ARD bEV proteome and peptidome showed overlapping alterations in neuronal connectivity, synaptic integrity, neuroinflammation, and metabolism. Unsupervised clustering analysis of correlated bEV/pEV markers stratified SZ patients into two clusters: high dementia risk and control-like profiles. Collectively, these data emphasize the significance of bEVs as crucial mediators of shared neuropathogenic mechanisms in SZ, and ARD. Furthermore, we identified a set of pEVs markers, including proteins and specific peptides, with a robust and promising bench-to-bedside trajectory that may facilitate the stratification of SZ patients at risk for ARD.
dc.description.abstract
The authors are pleased to acknowledge to Spanish Ministry of Science and Innovation, research project QUALISAFEJUICE PID-2019-106645RB-I00, for its financial support. I. Neggazi thanks the University of Lleida for its predoctoral grant (BOU204-220/2020 UdL) and the Serra Húnter contract awarded to Pilar Colás-Medà for supporting this work. This work also received support from the PT national funds (FCT/MECI, Fundação para a Ciência e Tecnologia and Ministério da Educação, Ciência e Inovação) through the project UID/50006 – Laboratório Associado para a Química Verde - Tecnologias e Processos Limpos. This study was also funded by the PRR – Plano de Recuperação e Resiliência and by the NextGenerationEU funds at Universidade de Aveiro, through the scope of the Agenda for Business Innovation “Plataforma de Valorização, Industrialização e Inovação comercial para o AgroAlimentar (VIIAFOOD)” (Project no. 37 AAC n.° 02/C05-i01/2022 with the application C644929456-00000040).
dc.publisher
Springer Nature
dc.relation
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-114885RB-C21/ES/CARACTERIZACION DE LAS VESICULAS EXTRACELULARES DERIVADAS DEL MICROBIOMA ORAL CIRCULANTES Y PRESENTES EN CEREBRO EN LA ENFERMEDAD DEL ALZHEIMER POR BIOLOGIA DE SISTEMAS/
dc.relation
info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023/PI22%2F00443/ES/Marcadores de pronóstico y estratificación en vesículas extracelulares cerebrales circulantes en plasma para identificar alteraciones incipientes de la unidad neurovascular en el Alzhéimer/
dc.relation
MICINN/PN2017-2020/PID2019-106645RB-I00
dc.relation
Reproducció del document publicat a https://doi.org/10.1186/s40478-026-02223-z
dc.relation
Acta Neuropathologica Communications, 2026, vol. 14, núm. 1, 41
dc.rights
cc-by-nc-nd, (c) Jose Antonio Sánchez Milán et al., 2026
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
info:eu-repo/semantics/openAccess
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Alzheimer’s disease
dc.subject
Biomarker discovery
dc.subject
Dementia risk stratification
dc.subject
Vascular dementia
dc.title
Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion